Integration-deficient Lentiviral Vectors: A Slow Coming of Age

Cited by (222)

Items 101–200 of 222

1. Virally mediated gene manipulation in the adult CNS
   Efrat Edry, Raphael Lamprecht, Shlomo Wagner, Kobi Rosenblum · 2011 · Frontiers in Molecular Neuroscience
2. Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination
   Atıl Bişgin, Ahter Dilşad Şanlioğlu, Yunus Emre Ekşi, Thomas S. Griffith, Salih Şanlıoğlu · 2021 · Human Gene Therapy
3. A single amino acid switch converts the Sleeping Beauty transposase into an efficient unidirectional excisionase with utility in stem cell reprogramming
   Lisa Kesselring, Csaba Miskey, Cecilia Zuliani, Irma Querques, Vladimir V. Kapitonov, Andrea Laukó, Anita Fehér, Antonio J. Palazzo, Tanja Diem, Janna Lustig et al. · 2019 · Nucleic Acids Research
4. In vivo liver targeted genome editing as therapeutic approach: progresses and challenges
   Chiara Simoni, Elena Barbon, Andrés Fernando Muro, Alessio Cantore · 2024 · Frontiers in Genome Editing
5. Nonintegrating Foamy Virus Vectors
   David R. Deyle, Yi Li, Erik M. Olson, David W. Russell · 2010 · Journal of Virology
6. Evaluating Nonintegrating Lentiviruses as Safe Vectors for Noninvasive Reporter-Based Molecular Imaging of Multipotent Mesenchymal Stem Cells
   Hamilton, Amanda M., Foster, Paula J., Ronald, John A. · 2018 · Human Gene Therapy
7. Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors
   Nicolas Grandchamp, Dorothée Henriot, Stéphanie Philippe, Lahouari Amar, Suzanna Ursulet, Ché Serguera, Jacques J. Mallet, Chamsy Sarkis · 2011 · Genetic Vaccines and Therapy
8. Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies
   Amrutha Banda, Olivia Impomeni, Aparana Singh, Abdul Rasheed Baloch, Wenhui Hu, Dabbu Kumar Jaijyan · 2024 · Vaccines
9. Designing Lentiviral Gene Vectors
   Oleg E. Tolmachov, Tanya Tolmachova, Faisal A. · 2011 · InTech eBooks
10. Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant
    Muhammad Qamar Saeed, Noëlle Dufour, Cynthia Bartholmae, Urzula Sieranska, Malaika Knopf, Eloïse Thierry, Sylvain Thierry, Olivier Delelis, Nicolas Grandchamp, Héloïse Pilet et al. · 2014 · Molecular Therapy — Nucleic Acids
11. Hybrid Lentiviral Vectors
    Waseem Qasim, Conrad A. Vink, Adrian James Thrasher · 2010 · Molecular Therapy
12. Protection is not always a good thing: The immune system’s impact on gene therapy
    Martiela Vaz de Freitas, Lariane Frâncio, Laura Haleva, Úrsula da Silveira Matte · 2022 · Genetics and Molecular Biology
13. Delivering the Goods for Genome Engineering and Editing
    Kristian Alsbjerg Skipper, Jacob Giehm Mikkelsen · 2015 · Human Gene Therapy
14. Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
    Gallinaro, Alessandra, Borghi, Martina, Pirillo, Maria Franca, Cecchetti, Serena, Bona, Roberta, Canitano, Andrea, Michelini, Zuleika, Di Virgilio, Antonio, Olvera, Alex, Brander, Christian et al. · 2020 · Molecular Therapy - Methods & Clinical Development
15. Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors
    Peirong Hu, Yedda Li, Mark S. Sands, Thomas J. McCown, Tal Kafri · 2015 · Molecular Therapy — Methods & Clinical Development
16. Lentiviral Vectors: From Wild-Type Viruses to Efficient Multi-Functional Delivery Vectors
    Ane Arrasate, Carlos Lopez-Robles, Miren Zuazo, Soledad Baños-Mateos, César Martı́n, Andrés Lamsfus‐Calle, Marie J. Fertin · 2025 · International Journal of Molecular Sciences
17. Gene editing in common cardiovascular diseases.
    Anna-Maria Lauerer, Xurde M. Caravia, Lars S. Maier, Francesco Chemello, S. Lebek · 2024 · Pharmacology and Therapeutics
18. Viral vectors for cystic fibrosis gene therapy: What does the future hold?
    Uta Griesenbach D, Inoue, Hasegawa, Eric W.F.W. Alton · 2010 · Virus Adaptation and Treatment
19. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
    Joshua Kuruvilla, Andrew Octavian Sasmita, Anna Pick Kiong Ling · 2018 · Neurological Sciences
20. Tax Induces the Recruitment of NF-κB to Unintegrated HIV-1 DNA To Rescue Viral Gene Expression and Replication
    Ishak D. Irwan, Bryan R. Cullen · 2021 · Journal of Virology
21. Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
    Alessandra Rossi, Zuleika Michelini, Pasqualina Leone, Martina Borghi, Maria Blasi, Roberta Bona, Massimo Spada, Felicia Grasso, Alessio Gugliotta, Mary E. Klotman et al. · 2014 · PLoS ONE
22. Next-generation biological vector platforms for in vivo delivery of genome editing agents
    Delphine Leclerc, Michael D. Siroky, Shannon M. Miller · 2023 · Current Opinion in Biotechnology
23. The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
    Sabina Sánchez-Hernández, Alejandra Gutiérrez-Guerrero, Rocío Martín-Guerra, Marina Cortijo-Gutierréz, María Tristán‐Manzano, Sandra Rodríguez, Laura Sánchez, Jose Luis Garcia-Perez, Jesús Chato‐Astrain, Ricardo Fernández‐Valadés et al. · 2018 · Molecular Therapy — Nucleic Acids
24. Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress
    Zhuoying Ren, Jun Zhou, Dongshan Yang, Yanhong Guo, Jifeng Zhang, Jie Xu, Y Eugene Chen · 2026 · Cells
25. Development and validation of optimized lentivirus-like particles for gene editing tool delivery with Gag-Only strategy
    Jinlin Jia, Yanzhe Hao, Pengfei Zhang, Xiaofang Cao, Lisha An, Hu Wang, Qi Ma, Xiaohua Jin, Xu Ma · 2025 · European journal of medical research
26. Improved retroviral episome transfer of transcription factors enables sustained cell fate modification
    J. Schott, D. Hoffmann, T. Maetzig, Franz-Josef Müller, D. Steinemann, D. Zychlinski, T. Cantz, C. Baum, A. Schambach · 2014 · Gene Therapy
27. Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems
    Cristina Fillat, Anabel José, Xavier Bofill‐De Ros, Ana Mato-Berciano, María Victoria Maliandi, Luciano Sobrevals · 2011 · Cancers
28. Retrovirus-based vectors for transient and permanent cell modification
    Juliane Wilhelmine Schott, Dirk Hoffmann, Axel Schambach · 2015 · Current Opinion in Pharmacology
29. Adeno-associated virus Rep-mediated targeting of integrase-defective retroviral vector DNA circles into human chromosome 19
    ShuoHao Huang, Yoshinori Kawabe, Akira Itô, Masamichi Kamihira · 2011 · Biochemical and Biophysical Research Communications
30. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
    Roberta Bona, Zuleika Michelini, Chiara Mazzei, Alessandra Gallinaro, Andrea Canitano, Martina Borghi, Maria Fenicia Vescio, Antonio Di Virgilio, Maria Franca Pirillo, Mary E. Klotman et al. · 2021 · Molecular Therapy — Methods & Clinical Development
31. Tackling Obstacles for Gene Therapy Targeting Neurons: Disrupting Perineural Nets with Hyaluronidase Improves Transduction
    Klaus Wanisch, Stjepana Kovac, Stéphanie Schorge · 2013 · PLoS ONE
32. Gene therapy for Parkinson’s disease: state-of-the-art treatments for neurodegenerative disease
    Michael R. Douglas · 2013 · Expert Review of Neurotherapeutics
33. Activation of EphA Receptors Mediates the Recruitment of the Adaptor Protein Slap, Contributing to the Downregulation ofN-Methyl- d -Aspartate Receptors
    Sophia Semerdjieva, Hayder H. Abdul-Razak, Sharifah S. Salim, Rafael J. Yáñez‐Muñoz, Philip E. Chen, Victor S. Tarabykin, Pavlos Alifragis · 2013 · Molecular and Cellular Biology
34. Delivery Methods, Resources and Design Tools in CRISPR/Cas
    Muhammad Aamir Aslam, Masooma Hammad, Aftab Ahmad, Josef Altenbuchner, Hazrat Ali · 2021 · Springer eBooks
35. Gene editing monkeys: Retrospect and outlook
    Weizheng Liang, Junli He, Chenyu Mao, Chengwei Yu, Qingxue Meng, Jun Wu Xue, Xueliang Wu, Shanliang Li, Yukai Wang, Hongyang Yi · 2022 · Frontiers in Cell and Developmental Biology
36. Losing, preserving, and restoring vision from neurodegeneration in the eye
    Daniel Kerschensteiner · 2023 · Current Biology
37. Improving the Transduction of Bone Marrow–Derived Cells with an Integrase-Defective Lentiviral Vector
    S. Louise Pay, Xiaoping Qi, Jeffrey F. Willard, Juliana Aparecida Preto de Godoy, Kavya Sankhavaram, Ranier Horton, Sayak K. Mitter, Judith Quigley, Lung‐Ji Chang, Maria B. Grant et al. · 2017 · Human Gene Therapy Methods
38. Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells
    Yan Xu, Dan Wang, Li-Mei Zhao, Xilong Zhao, Junjie Shen, Yao Xie, Lili Cao, Zhen-bo Chen, Yanmei Luo, Bihui Bao et al. · 2013 · Cancer Biology & Therapy
39. Lentiviral Vectors Encoding Zinc-Finger Nucleases Specific for the Model Target Locus HPRT1
    Laetitia P.L. Pelascini, Manuel A.F.V. Gonçalves · 2014 · Methods in molecular biology
40. Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
    Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, Andrea Canitano, Zuleika Michelini, Maria Laura De Angelis, Serena Cecchetti, Antonella Tinari, Chiara Falce, Sabrina Mariotti et al. · 2023 · Frontiers in Immunology
41. Precise Gene Knock‐In Tools with Minimized Risk of DSBs: A Trend for Gene Manipulation
    Y.H. Liu, Jianping Kong, Gongyu Liu, Zhaoxing Li, Yibei Xiao · 2024 · Advanced Science
42. CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals
    Janardhan Keshav Karapurkar, Ainsley Mike Antao, Kye-Seong Kim, Suresh Ramakrishna · 2021 · Progress in molecular biology and translational science
43. Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens
    Ting Wang, Lilan Zheng, Qiujian Zhao, Yazhou Yao, Feng Zhou, Fang Wei, Qiliang Cai · 2023 · Journal of Medical Virology
44. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers
    Alessandra Gallinaro, Maria Franca Pirillo, Yoann Aldon, Serena Cecchetti, Zuleika Michelini, Antonella Tinari, Martina Borghi, Andrea Canitano, Paul F. McKay, Roberta Bona et al. · 2022 · npj Vaccines
45. Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 -deficient chronic granulomatous disease
    Kah Mun Siow, Merve Güngör, Dominik Wrona, Federica Raimondi, Oleksandr Pastukhov, Panagiotis Tsapogas, Timon Menzi, Michael Schmitz, Péter István Kulcsár, Gerald Schwank et al. · 2024 · Molecular Therapy — Nucleic Acids
46. Lentiviral vectors for cutaneous RNA managing
    Maria Nascimento Primo, Rasmus Otkjær Bak, Jacob Giehm Mikkelsen · 2011 · Experimental Dermatology
47. Promising Gene Therapeutics for Salivary Gland Radiotoxicity
    Renjith Parameswaran Nair, Gulshan Sunavala‐Dossabhoy · 2016 · AIMS Medical Science
48. Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency
    Hayder H. Abdul-Razak, Céline J. Rocca, Steven J. Howe, María Eugenia Alonso-Ferrero, J. Wang, R. Gabriel, Cynthia C. Bartholomae, Victor Chih Hao Gan, Marina Inmaculada Garin, Amy L. Roberts et al. · 2018 · Scientific Reports
49. Comparison of transduction efficiency among various lentiviruses containing GFP reporter in bone marrow hematopoietic stem cell transplantation
    Nan Wang, Narendiran Rajasekaran, Tieying Hou, Leszek Lisowski, Elizabeth Mellins · 2013 · Experimental Hematology
50. Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats
    Ngoc Lu‐Nguyen, Martin Broadstock, Rafael J. Yáñez‐Muñoz · 2015 · Human Gene Therapy
51. The interplay of post-translational modification and gene therapy
    Victor Chukwudi Osamor, Shalom Nwodo Chinedu, Dominic E. Azuh, Emeka Iweala, Olubanke Olujoke Ogunlana · 2016 · Drug Design Development and Therapy
52. Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism
    Siyuan Ma, Mengjiao Lv, Xiaohua Chen, Guoqing Zang, Zhenghao Tang, Yi Zhang, Weiwei Hu · 2023 · Antiviral Research
53. Targeted Lentiviral Vectors: Current Applications and Future Potential
    Cleo Goyvaerts, Thérèse Liechtenstein, Christopher Bricogne, David Escors, Karine Breckpot · 2013 · InTech eBooks
54. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line
    Fazlina Nordin, Zariyantey Abdul Hamid, Lucas Chan, Farzin Farzaneh, Muhammad Khairul Azaham Abdul Hamid · 2016 · Methods in molecular biology
55. Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration‐deficient retroviral vectors
    Juliane Wilhelmine Schott, Nico Martin Jäschke, Dirk Hoffmann, Tobias Maetzig, Matthias Ballmaier, Tamaryin Godinho, Toni Cathomen, Axel Schambach · 2015 · Cytometry Part A
56. Retroviral Vectors in Gene Therapy
    Miroslava Matúšková, Erika Durinikov · 2016 · InTech eBooks
57. Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectors
    María Eugenia Alonso-Ferrero, Niek P. van Til, Kerol Bartolović, Márcia F. Mata, Gerard Wagemaker, DALE A. MOULDING, David A. Williams, Christine Kinnon, Simon N. Waddington, Michael D. Milsom et al. · 2017 · Experimental Hematology
58. Current research on SMN protein and treatment strategies for spinal muscular atrophy
    Emma Humphrey, Heidi R. Fuller, Glenn E. Morris · 2011 · Neuromuscular Disorders
59. Assessment of Different Virus-Mediated Approaches for Retinal Gene Therapy of Usher 1B
    Vanda S. Lopes, Tanja Diemer, David S. Williams · 2014 · Advances in experimental medicine and biology
60. Adeno-Associated Vectors for Gene Delivery to the Nervous System
    Pádraig J. Mulcahy, Christopher Binny, Bartosz Muszynski, Evangelia Karyka, Mimoun Azzouz · 2015 · Neuromethods
61. Advances in Molecular Retrovirology
    Shailendra Kumar Saxena · 2016 · InTech eBooks
62. Perspectives of Genome-Editing Technologies for HIV Therapy
    Hirotaka Ebina, Peter Gee, Yoshio Koyanagi · 2015 · Current HIV Research
63. TATκ Fusion Protein of OCT-3/4 and KLF-4: Stable Mixed Population Cell Lines Capable of Delivering Fusion Proteins to Target Cells
    Fazlina Nordin Gee Jun Tye · 2014 · Journal of Cell Science & Therapy
64. Exploring Caspase-3 overexpression in pheochromocytoma cells: Implications for cancer therapy
    Razieh Zare, Rita Arabsolghar, Abbas Behzad‐Behbahani, Farahnaz Zare, Ali Kheirandish, Fatemeh Safari · 2025 · Tissue and Cell
65. Rewriting the script: gene therapy and genome editing for von Willebrand Disease
    Alastair Barraclough, Isabel Bär, Tirsa T van Duijl, Karin Fijnvandraat, Jeroen C.J. Eikenboom, Frank W.G. Leebeek, Ruben Bierings, Jan Voorberg, Despoina Trasanidou · 2025 · Frontiers in Genome Editing
66. Lentivector Vaccines
    Paul D. Bryson, Pin Wang · 2013 · Elsevier eBooks
67. Replicating Minicircles: Overcoming the Limitations of Transient and Stable Expression Systems
    Kristina Nehlsen, Sandra Broll, Raju Kandimalla, Niels Heinz, Markus Andree Heine, Stefanie Binius, Axel Schambach, Jürgen Bode · 2013 · Wiley eBooks
68. Delivery Systems for Therapeutic Genome Editing: Challenges, Innovations, and Future Perspectives
    Meijia Yang, Yiqiong Song, Ziyang Wang, Ke Chao, Lifeng Li, Xu Zhang, Xiaoran Duan, Chenglong Yu, Ruyue Xue, Jie Zhao · 2026 · MedComm
69. Dendritic Cells and Lentiviral Vectors: Mapping the Way to Successful Immuno Gene Therapy
    Cleo Goyvaerts, Grazyna T. Kochan, David Escors, Karine Breckpot · 2011 · InTech eBooks
70. Transgene expression in various organs post BM-HSC transplantation
    Nan Wang, Narendiran Rajasekaran, Tieying Hou, Elizabeth Mellins · 2013 · Stem Cell Research
71. CRISPR deletions in cell lines for reconstitution studies of pseudokinase function
    Annette V. Jacobsen, James M. Murphy · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
72. Intrastriatal Delivery of Integration-Deficient Lentiviral Vectors in a Rat Model of Parkinson’s Disease
    Ngoc Lu‐Nguyen, Martin Broadstock, Rafael J. Yáñez‐Muñoz · 2016 · Methods in molecular biology
73. Transgene Delivery to Endothelial Cultures Derived from Porcine Carotid Artery Ex Vivo
    Joycelyn Andoh, B. Sawyer, Kinga A. Szewczyk, Mei Nortley, T. Rossetti, I.M. Loftus, Rafael J. Yáñez‐Muñoz, Atticus H. Hainsworth · 2013 · Translational Stroke Research
74. Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo
    Scott Ellis, Liang Fong-Wong, Sharifah Iqball, Vinay Thoree, Kyriacos A. Mitrophanous, Katie Binley · 2012 · Molecular Therapy — Nucleic Acids
75. Engineered Viruses as Vaccine Platforms
    Antonella Folgori, Stefania Capone · 2012 · Springer eBooks
76. Viral vectors for gene delivery
    Katharine J. Liang, Richard Jude Samulski · 2015
77. Development of viral & non-viral episomal vectors for gene therapy applications
    Hanna Kymäläinen · 2012 · OpenGrey (Institut de l'Information Scientifique et Technique)
78. The Control and Trust of CRISPR / Cas9 Genome Altering for Clinical Application with Gene Treatment and Treatment of Hereditary Diseases
    Hossein Soltaninejad, Mohadeseh Khoshandam, Amir Ali Hamidieh, Saman Hosseinkhani · 2022
79. Optogenetic enzymes: A deep dive into design and impact
    Tanaya Basu Roy, Mana Heidari, Nikolay V. Dokholyan · 2025 · Current Opinion in Structural Biology
80. The molecular composition of JRAB/MICAL-L2 droplets controls site-specific actin bundle morphology to drive cell–cell adhesion
    Ayuko Sakane, Christian Ganser, Kazuki Horikawa, Chie Sakamoto, Mayu Sakai, Maho Okada, Nodoka Ono, Natsuki Matsushita, Hiroshi Yamada, Kohji Takei et al. · 2026 · Journal of Cell Science
81. Recent Advances and Future Perspectives in Lentiviral Gene Therapy for Hemophilia A and B
    Janka Mátrai, Marinee Chuah, Thierry VandenDriessche · 2012 · Journal of Genetic Syndromes & Gene Therapy
82. A Southern Blot Protocol to Detect Chimeric Nuclease-Mediated Gene Repair
    Céline J. Rocca, Hayder H. Abdul-Razak, Michael C. Holmes, Philip D. Gregory, Rafael J. Yáñez‐Muñoz · 2014 · Methods in molecular biology
83. Murine Granulocyte–Macrophage Colony-Stimulating Factor Expressed from a Bicistronic Simian Immunodeficiency Virus-Based Integrase-Defective Lentiviral Vector Does Not Enhance T-Cell Responses in Mice
    Zuleika Michelini, Donatella R. M. Negri, Mirella Biava, Silvia Baroncelli, Massimo Spada, Pasqualina Leone, Roberta Bona, Maria Blasi, Didier Négre, Mary E. Klotman et al. · 2014 · Viral Immunology
84. Perspectives for the future developments of gene therapy for autoimmune and inflammatory therapy
    Yuti Chernajovsky, Paul D. Robbins · 2010 · Springer eBooks
85. Turning Tables for CRISPR/Cas9 Editing System: From Scratch to Advanced Delivery Platforms
    Sergiu Chira, Andreea Mihaela Nutu, Cecilia Bica, Laura Pop, Mihai Gherman, Mihai-Daniel Angheluță, Ioana Berindan‐Neagoe · 2022 · Springer eBooks
86. Lentiviral target-specific strategy for molecular therapy
    Lídia Fonseca · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
87. Robust Adaptive Control of Switched Systems
    Khalid El, Kamal Youcef‐Toumi · 2009 · InTech eBooks
88. Lentivector based gene transfer for immunotherapy – application of integration deficient vectors and PDL1knockdown as tools to manipulate immune responses
    Katarzyna Karwacz · 2012 · UCL Discovery (University College London)
89. Role of Actin-mediated Motility of Peripheral Astrocytic Processes in Synaptic Function
    Dmitry Molotkov · 2014 · Työväentutkimus Vuosikirja
90. Adenovirus-based gene therapy approaches for hemophilia B
    Wenli Zhang · 2012 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
91. Cell Models Adapted to Real-Time Imaging of the Cytoskeleton Dynamics in Altered Gravity
    Jérôme Willems, Christophe Deroanne, Alain Colige, Nancy Garbacki · 2014 · Microgravity Science and Technology
92. Assessing the potential of non-integrating lentiviral vectors for cardiovascular gene therapy
    Helen Elizabeth Chick · 2011 · Enlighten: Theses (The University of Glasgow)
93. Estudio de la función de FASTKD3 en la mitocondria
    Rebeca Torres Merino · 2015
94. Factors affecting the formation, stability, and expression of unintegrated lentiviral vector genomes
    Matthew Bayer · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
95. Strategies for the Gene Modification of Megakaryopoiesis and Platelets
    Lisette J. Latorre-Rey, Ute Modlich · 2016 · Springer eBooks
96. Viral Vectors for Delivering Gene Material into Cells and Their Application in Neurobiology (Review)
    Ekaterina A. Epifanova, Ekaterina V. Borisova, V.A. Salina, Alexey A. Babaev · 2017 · Современные технологии в медицине
97. MDS1/EVI1 and PRDM16 deregulation in hematopoiesis after experimental and clinical gene transfer
    Wang, Wei · 2012 · heiDOK (Heidelberg University)
98. A systemically-delivered stem cell therapy for dry age related macular degeneration
    S. Louise Pay · 2017 · IUScholarWorks (Indiana University)
99. In utero gene delivery to spinal cord motor neurons
    Kinam Park · 2018 · Journal of Controlled Release
100. HEMATOPOIETIC STEM CELL GENE THERAPY FOR INHERITED MONOGENIC DISEASES AND ITS IMPLICATIONS FOR FUTURE GENE THERAPY TRIALS IN TURKEY
     Fatima Aerts‐Kaya, Gülen Güney-Esken, Özgür Doğuş Erol · 2019 · Trakya University Journal of Natural Sciences